drug association Videos
-
BIT225 active against SARS-CoV-2 in an animal model of COVID-19 - Video
Biotron Limited (ASX:BIT) held a webinar today to update investors on its latest news on its lead clinical stage antiviral drug BIT225. BIT225 has shown significant and clinically relevant activity in an animal model of COVID-19. The drug prevented the development of severe disease, reduced pro-inflammatory cytokines associated with "cytokine storms" that are linked to severe disease and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you